Digg It
#1 in Business Subscribe Email Print

You are here: Home > Business > Marketing Direct > Direct Mail - The Deadly Sin Of Not Testing

Tags

  • shows
  • choice
  • device
  • combination products
  • companies involved

  • Links

  • Last Will and Testament Software
  • Cambridge Tours
  • Trouble-Free Gardening With Antique Roses
  • Digg It - Direct Mail - The Deadly Sin Of Not Testing

    If there's one thing that makes direct mail a reliable method of drumming up new business, then that would have to be the ability to test if different version of a pack achieve a better return on investment. Ha
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    ving processed many mailings over the years, I can attest that clients rarely take full advantage of this feature. In fact, more often than not, clients don't test at all.

    Not testing is commercial suicide. In
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    today's competitive climate, if there is anything that can be done to reduce the cost of acquiring a customer, then it must be done. It's a no brainer. Research shows that in times of depression, those that con
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    tinue to advertise are those that do well. It also shows that those that continue to advertise also make efforts to stretch their budget even further.

    You decrease your direct mail costs by application of a li
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    tle commonsense and by testing which produces the best response. We'll take the example of direct mail pack that comprises five parts in all. The parts of the pack are as follows:

    1) Envelope
    2) Personal
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    ised letter
    3) Brochure
    4) Leaflet/Order form
    5) Business reply Envelope


    Looking at this you would think that this it, but we've forgotten the most important part of all:


    6) The data
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc


    So, there's enough there now to get your message out.

    Experience shows that the most important part of the mailing is the data, so we must test this part. A badly produced but well targeted letter will almos
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    t certainly produce a better return than a well written badly targeted letter.

    You may have a particular target audience already decided, for example, lawyers. You will be able to get lists of lawyers from mor
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    than one source, that can be tested. Equally you'll have the option of mailing to a named individual, or to a job title, so you can test that too. So far that's at least four permutations provided you use 2 da
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    ta suppliers. It would be 6 if you used 3 suppliers. If you hadn't narrowed your field to one sector, then the choice of tests to run could be massively increased, but it's not practical to take it to the extre
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    e.

    Targeting is everything, you must get that right, and you can only find that out if you test.

    Looking at the envelope, you have a huge number of choice here too. You can send plain with a stamp, or printed
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    with a message. You could make the material from an unusual paper, print in full colour, use different sizes. You could print different designs, use different taglines and the like.

    Depending on how your enve
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    ope is made you may be able to run multiple designs for a minimal charge. The nature of some jobs is that they are printed 2 or 3 or up on a sheet, so you will be able to produce equal quantities of more than o
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    ne design. Even if it's not free, chances are that it won't be hat expensive for a plate change.

    For the letterhead, you can change the material. Studies by paper merchants have shown a 20% increase in respons
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    just by changing to a textured paper. The copy itself on the letter can be changed, offers can be changed. The number of options to test here is almost limitless.

    Moving on to the leaflet, the same applies he
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    re as did for the letterhead. Copy, material, imagery; they're all fair game.

    Last but not least we move on to the BRE. There's not a huge amount you could do here. White or manila envelopes perhaps? Maybe eve
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    a coloured BRE? if it isn't going to cost a lot, why not try it.

    Using these methods over time you can increase the effectiveness of your mailings. Always test, even when you think you have the perfect pack,
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    continue to run a test campaign against it, even if the difference between the two is really quite small. If you continue to do this, your costs to acquire a customer should fall and fall.

    Overall, the point i
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    that there an almost infinitely large and almost limitless opportunity for testing. Maybe it's this huge scope for testing that puts people off, but I don't think it is. I think it's just a lack of awareness o
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    f what you can do. You don't need to complicate things, you can just run two packs with one difference between them and see how it goes.

    Whatever you do though, don't commit commercial suicide and fail to test


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.diggit.org.ua/article/30533/diggit-Direct-Mail--The-Deadly-Sin-Of-Not-Testing.html">Direct Mail - The Deadly Sin Of Not Testing</a>

    BB link (for phorums):
    [url=http://www.diggit.org.ua/article/30533/diggit-Direct-Mail--The-Deadly-Sin-Of-Not-Testing.html]Direct Mail - The Deadly Sin Of Not Testing[/url]

    Related Articles:

    More Cheap Tricks for Promoting Your Business

    What Do You Do for a Living? or Why Our Titles Say Nothing About Our Work

    Looking For a New Job? Are You Sure You Can Pass the Background Check?

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com